© 1991 British Society for Rheumatology
case-report |
NON-INFECTIVE VERRUCOUS ENDOCARDITIS IN A PATIENT WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME


Systemic Autoimmune Diseases Research Unit, Department of Internal Medicine, Hospital Clinic Barcelona, Spain
*Lupus Arthritis Research Unit, Rayne institute, St Thomas' Hospital London, UK
Department of Cardiology, Hospital Clinic Barcelona, Spain
Correspondence to:
Correspondence to: Dr J. Font. Servei de Medicina Interna General. Unitat 1. Hospital Clinic. Villarroel. 170. 08036 Barcelona. Spain
A 27-year-old women with primary antiphospholipid syndrome, who developed a haemodynamically significant non-infective verrucous endocarditis is reported. Her mother suffered from antiphospholipid syndrome associated with systemic lupus erythematosus. A pathogenetic role of antiphospholipid antibodies in heart valve lesions is suggested.
KEY WORDS: Venous thrombosis, Lupus anticoagulant, Mitral valve thickening, Heart failure, Systemic lupus erythematosus
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Hojnik, J. George, L. Ziporen, and Y. Shoenfeld Heart Valve Involvement (Libman-Sacks Endocarditis) in the Antiphospholipid Syndrome Circulation, April 15, 1996; 93(8): 1579 - 1587. [Abstract] [Full Text] |
||||
![]() |
R. Cervera, M. A. Khamashta, J. Font, P. A. Reyes, J. L. Vianna, A. Lopez-Soto, M.-C. Amigo, R. A. Asherson, M. Azqueta, C. Pare, et al. High Prevalence of Significant Heart Valve Lesions in Patients with the 'Primary' Antiphospholipid Syndrome Lupus, November 1, 1991; 1(1): 43 - 47. [Abstract] [PDF] |
||||

